Merck’s (NYSE:MRK) Q4 Sales Top Estimates But Stock Drops
Global pharmaceutical company Merck (NYSE:MRK) reported Q4 CY2024 results , with sales up 6.8% year on year to $15.62 billion. On the other hand, the company’s full-year revenue guidance of $64.85 billion at the midpoint came in 3.
Merck stock slides as 2025 earnings outlook misses estimates
Merck (MRK) shares drop 8% premarket as 2025 outlook falls short of Wall Street estimates, despite beating Q4 expectations with Keytruda sales.
Merck Earnings Rise; 2025 Outlook Hits Shares
Merck swung to a quarterly profit as sales grew to beat Wall Street’s estimates, although the drug company’s outlook for 2025 and a slide in sales of its HPV vaccine hit shares.
Merck beats estimates on fourth-quarter on earnings—but stock slides pre-market on tepid 2025 guidance
Merck (MRK) reported fourth quarter and full year earnings Tuesday, in line with Wall Street estimates. The bad news: Its stock was down more than 8% in pre-market trading, largely because of weaker than expected 2025 guidance.
Merck shares tumble on Q4 earnings miss, weak 2025 guidance
Merck & Company Inc (NYSE:MRK) shares tumbled more than 8% on pre-market trading on Tuesday after reporting mixed fourth-quarter results, with earnings falling short of expectations, revenue surpassing estimates and full-year guidance coming in below analyst projections.
Merck's Gardasil Vaccine Slowdown In China Bites Again, Stock Falls On Weak 2025 Outlook
Merck posted Q4 sales of $15.62 billion, driven by Keytruda's 19% growth. FY25 guidance lags estimates, citing Gardasil ...
bovnews16h
What’s Fueling Merck & Co Inc (MRK) Stock’s -13.64% Loss Below Its 200-Day SMA?
Truist has recently reduced Merck & Co Inc (MRK) stock to Hold rating, as announced on January 8, 2025, according to Finviz. Earlier, on December 20, 2024, BMO Capital Markets had reduced the stock ...
Merck Q4 2024 Earnings Preview: Headwinds ahead, but familiar strengths to persist
Truist Securities expressed confidence in its latest note that Merck will be able to navigate the upcoming Gardasil headwinds ...
Will These 5 Big Drug Stocks Surpass Q4 Earnings Forecasts?
Let's look at five pharma and drug companies, MRK PFE, LLY, AMGN and BMY, which are scheduled to release their fourth-quarter ...
Here’s Why Merck & Co., Inc. (MRK) Is Among the Highest Yielding Dividend Stocks In the Dow
We recently compiled a list of the 13 Highest Yielding Dividend Stocks in the Dow. In this article, we are going to take a ...
Earnings week ahead: PLTR, AMZN, GOOG, AMD, LLY, PEP, F, PFE, MRK, PYPL and more
The first full week of February brings a packed earnings calendar, featuring major names across sectors. Tech giants Amazon ...
Surprise, surprise: Insider chosen behind closed doors for city real estate project
In what the Union-Tribune described as a “behind-the-scenes real estate competition,” the City Council voted in closed ...
Nasdaq4d
MRK March 14th Options Begin Trading
Investors in Merck & Co Inc (Symbol: MRK) saw new options become available today, for the March 14th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MRK ...
Bank of America Securities Remains a Buy on Merck & Company (MRK)
Bank of America Securities analyst Tim Anderson reiterated a Buy rating on Merck & Company (MRK – Research Report) today and set a price ...
Zacks.com on MSN21h
MRK Gets Positive CHMP Nod for 21-Valent Pneumococcal Jab Capvaxive
Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of its 21-valent pneumococcal conjugate ...